Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Myriam Curet sold 3,031 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total value of $1,749,796.30. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $203,786.90. The trade was a 89.57 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Myriam Curet also recently made the following trade(s):
- On Thursday, February 27th, Myriam Curet sold 2,401 shares of Intuitive Surgical stock. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00.
- On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00.
Intuitive Surgical Trading Down 1.1 %
NASDAQ:ISRG traded down $6.17 during trading hours on Monday, reaching $566.98. 1,705,279 shares of the company were exchanged, compared to its average volume of 1,732,928. The firm has a market cap of $201.95 billion, a PE ratio of 88.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s 50-day moving average is $570.66 and its 200-day moving average is $530.08.
Institutional Trading of Intuitive Surgical
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on ISRG. Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.
Check Out Our Latest Analysis on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Should You Invest in Penny Stocks?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What Investors Need to Know About Upcoming IPOs
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.